News
The company is facing pressure on two fronts—the government and a host of new AI-powered search rivals. It has the capacity to meet both challenges and continue to prosper.
Regions Financial Corp. Dep. Pfd. (Rep. 1/40th Non-Cum. Perp. Pfd. Series C)-1.79% Regions Financial Corp. Dep. Pfd. (Rep. 1/40th Perp. Pfd. Series E)-1.89% ...
GM has struggled to sell its electric commercial vehicles in the U.S. CAMI Assembly took two weeks of previously planned downtime to align production schedules and balance inventor Before ...
Google offers a compelling investment opportunity at $170, with potential 50-100% upside over the next 3–5 years. GOOG leads in high-growth areas: digital ads, cloud computing, robotaxis, and ...
Forbes contributors publish independent expert analyses and insights. I write about how bitcoin, crypto and blockchain can change the world.
The company, started in 2021 by then 19-year-old Steven Wang, launched as the only regulated copy-trading platform in the United States that lets users mirror trades of politicians and hedge fund ...
Witchbrook is officially coming to Nintendo Switch (and probably to Switch 2 as well) at the end of the year, and it's likely to launch on PC on the same date. As for the other consoles, we’re not ...
Chris Gallant, CFA, is a senior manager of interest rate risk for ATB Financial with 10 years of experience in the financial markets. Yarilet Perez is an experienced multimedia journalist and fact ...
U.S. stock futures are little changed after three consecutive winning sessions for indexes; copper futures soar on a report that U.S. import tariffs on the metal could come sooner than expected ...
Amanda M. Castro is a Newsweek Live Blog Editor based in New York. Her focus is reporting on U.S. politics, breaking news, consumer topics, and entertainment. She specializes in delivering in ...
Petrana Radulovic is an entertainment reporter specializing in animation, fandom culture, theme parks, Disney, and young adult fantasy franchises. If you have been craving some good witch content ...
Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results